Simcha Therapeutics
- Biotech or pharma, therapeutic R&D
Simcha is the industry leader in IL-18 therapeutic development, with its first-in-class clinical-stage engineered decoy-resistant IL-18 agonist (ST-067); and unparalleled clinical, translational, and biology expertise
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}